title: Quantitative sensory testing: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
abstract: OBJECTIVE
  This assessment evaluates the clinical utility, efficacy, and safety of quantitative sensory testing (QST).
  
  
  METHODS
  By searching MEDLINE, Current Contents, and their personal files, the authors identified 350 articles. Selected articles utilized computer operated threshold systems, manually operated threshold systems, and electrical threshold devices. The authors evaluated the use of normal values and the degree of reproducibility between the same and different systems. Articles were rated using a standard classification of evidence scheme.
  
  
  RESULTS
  Because of differences between systems, normal values from one system cannot be transposed to others. Reproducibility of results was also an important concern, and there is no consensus on how it should be defined. The authors identified no adequately powered class I studies demonstrating the effectiveness of QST in evaluating any particular disorder. A number of class II and III studies demonstrated that QST is probably or possibly useful in identifying small or large fiber sensory abnormalities in patients with diabetic neuropathy, small fiber neuropathies, uremic neuropathies, and demyelinating neuropathy.
  
  
  CONCLUSIONS
  QST is a potentially useful tool for measuring sensory impairment for clinical and research studies. However, QST results should not be the sole criteria used to diagnose pathology. Because malingering and other nonorganic factors can influence the test results, QST is not currently useful for the purpose of resolving medicolegal matters. Well-designed studies comparing different QST devices and methodologies are needed and should include patients with abnormalities detected solely by QST.
authors.affiliation: Department of Neurology and Center for Molecular Medicine and Genetics, Wayne State University School of Medicine, Detroit, MI, USA.
authors.forename: M E
authors.initials: ME
authors.lastname: Shy
authors.forename: E M
authors.initials: EM
authors.lastname: Frohman
authors.forename: Y T
authors.initials: YT
authors.lastname: So
authors.forename: J C
authors.initials: JC
authors.lastname: Arezzo
authors.forename: D R
authors.initials: DR
authors.lastname: Cornblath
authors.forename: M J
authors.initials: MJ
authors.lastname: Giuliani
authors.forename: J C
authors.initials: JC
authors.lastname: Kincaid
authors.forename: J L
authors.initials: JL
authors.lastname: Ochoa
authors.forename: G J
authors.initials: GJ
authors.lastname: Parry
authors.forename: L H
authors.initials: LH
authors.lastname: Weimer
mesh_terms: D003929:Diabetic Neuropathies / Q000175:diagnosis / Q000503:physiopathology; D003943:Diagnostic Techniques, Neurological; D006801:Humans; D008137:Longitudinal Studies; D009437:Neuralgia / Q000175:diagnosis / Q000503:physiopathology; D015203:Reproducibility of Results; D012678:Sensation Disorders / Q000175:diagnosis / Q000503:physiopathology; D012680:Sensitivity and Specificity